2021 Vol.2 Sept.No3

• Title: Psychological nursing care of patients with cardiovascular and cerebrovascular complications of type 2 diabetes mellitus
• Name: Yasunori Masutani1,Makiko Ômoto2
• Company: (1.Suzuka University,Suzuka 510-0258,Japan; 2.Meiguang University,Shimonoseki 750-0000,Japan)
• Abstract:

  Objective: With the aging of population in modern society, the incidence of type 2 diabetes is increasing rapidly. This paper discusses the psychological nursing of diabetic patients with cardiovascular and cerebrovascular complications, and analyzes the quality of life of patients with complications. Methods: 140 patients with cardiovascular and cerebrovascular complications of type 2 diabetes mellitus in our hospital were selected, and divided into the control group and the experimental group with routine nursing according to the principle of voluntariness. The nursing effects of the two groups were compared. Results: The blood pressure, pulse pressure, systolic blood pressure, diastolic blood pressure and glucose and lipid metabolism indexes of patients were evaluated before and at 6 months after the intervention. The total scores of all indexes in the experimental group were higher than those in the control group, and the nursing effect of the experimental group (94.6%) was higher than that of the control group (81.4%), with statistical significance (P<0.05). Conclusion: Nursing staff should help patients with cardiovascular and cerebrovascular complications of type 2 diabetes to establish good living habits, effectively control diet, strengthen physical exercise and drug treatment, and improve their quality of life.

  
  

• Keyword: Type 2 diabetes; Cardiovascular and cerebrovascular diseases; Complications; Psychological nursing
• DOI: 10.12250/jpcarme2021020361
• Citation form: Yasunori Masutani1,Makiko Ômoto2.Psychological nursing care of patients with cardiovascular and cerebrovascular complications of type 2 diabetes mellitus.2020, vol. 3, 1-5.

[1]Carlos I, Kenneth J R, Mary S B, et al. Cardiovascular and cerebrovascular events among patients receiving omalizumab: Pooled analysis of patient-level data from 25 randomized, double-blind, placebo-controlled clinical trials[J].The Journal of allergy and clinical immunology,2017,139(5):1678-1680.

[2]Ascher S, Reinhardt C. The gut microbiota: An emerging risk factor for cardiovascular and cerebrovascular disease[J].European Journal of Immunology,2018,48(4):564-575.

[3]Ia A S, A V Kovalenko, E A Likhoshapko, et al. Indices of cerebrovascular reactivity in patients with diabetes mellitus complicated with cardiovascular autonomic neuropathy[J].Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova,2014,114(4):85-89.

[4]De, Mello, Walmor, et al. Local Renin Angiotensin Aldosterone Systems and Cardiovascular Diseases[J]. The Medical Clinics of North America, 2017, 101(1):117-127.

[5]Li J, Gao Y, Ren X, et al. The Role of Biologically Active Ingredients from Chinese Herbal Medicines in the Regulation of Autophagy in Treating Cardiovascular Diseases and Other Chronic Diseases[J].Current pharmaceutical design,2017,23(7):1060-1069.

[6]Foster G E, Hanly P J, Ostrowski M, et al. Ventilatory and cerebrovascular responses to hypercapnia in patients with obstructive sleep apnoea: effect of CPAP therapy.[J].Respiratory physiology & neurobiology,2009,165(1):73-81.

[7]Chen Y H, Feng B, Chen Z W. Statins for primary prevention of cardiovascular and cerebrovascular events in diabetic patients without established cardiovascular diseases: A meta-analysis[J].Experimental and clinical endocrinology and diabetes: Official journal, German Society of Endocrinology [and] German Diabetes Association,2012,120(2):116-120.